Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001906152 | SCV002160154 | likely benign | Holocarboxylase synthetase deficiency | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004631802 | SCV005128113 | uncertain significance | Inborn genetic diseases | 2024-06-07 | criteria provided, single submitter | clinical testing | The c.1033C>A (p.Q345K) alteration is located in exon 6 (coding exon 3) of the HLCS gene. This alteration results from a C to A substitution at nucleotide position 1033, causing the glutamine (Q) at amino acid position 345 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |